
In episode 8, we sit down with Ray Dolby Brain Health Center Medical Director Armen Moughamian MD PhD to discuss the latest research and headlines in Alzheimer's disease. We cover the process of taking a new treatment from the lab to the patient, why drug development is especially difficult for Alzheimer's disease, and give our opinions about some of the latest splashy headlines and areas of exciting new research.
Articles mentioned in the podcast:
Lithium:
Clinical trial: https://jamanetwork.com/journals/jamaneurology/fullarticle/2845746
Animal study:
https://www.nature.com/articles/s41586-025-09335-x
Focused Ultrasound for Amyloid Antibodies:
https://www.nejm.org/doi/full/10.1056/NEJMoa2308719
Cochrane Review Amyloid Antibodies:
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD016297/full
Trontinemab:
https://www.alzforum.org/therapeutics/trontinemab
GLP1 Clinical Trial (EVOKE/EVOKE+):
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00459-9/fulltext
More episodes from "Confronting Dementia"



Don't miss an episode of “Confronting Dementia” and subscribe to it in the GetPodcast app.






